176 related articles for article (PubMed ID: 11595126)
1. Newcastle disease virus therapy of human tumor xenografts: antitumor effects of local or systemic administration.
Phuangsab A; Lorence RM; Reichard KW; Peeples ME; Walter RJ
Cancer Lett; 2001 Oct; 172(1):27-36. PubMed ID: 11595126
[TBL] [Abstract][Full Text] [Related]
2. Complete regression of human neuroblastoma xenografts in athymic mice after local Newcastle disease virus therapy.
Lorence RM; Reichard KW; Katubig BB; Reyes HM; Phuangsab A; Mitchell BR; Cascino CJ; Walter RJ; Peeples ME
J Natl Cancer Inst; 1994 Aug; 86(16):1228-33. PubMed ID: 8040891
[TBL] [Abstract][Full Text] [Related]
3. Complete regression of human fibrosarcoma xenografts after local Newcastle disease virus therapy.
Lorence RM; Katubig BB; Reichard KW; Reyes HM; Phuangsab A; Sassetti MD; Walter RJ; Peeples ME
Cancer Res; 1994 Dec; 54(23):6017-21. PubMed ID: 7954437
[TBL] [Abstract][Full Text] [Related]
4. [Anti-tumor effect of Newcastle disease virus strain D817 against nude mouse xenografts of human colon carcinoma].
Huang C; Fan XH; Jiang YH; Song DZ; Gao LQ; Huang QG; Lai ZP
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):490-4. PubMed ID: 19950694
[TBL] [Abstract][Full Text] [Related]
5. Newcastle disease virus selectively kills human tumor cells.
Reichard KW; Lorence RM; Cascino CJ; Peeples ME; Walter RJ; Fernando MB; Reyes HM; Greager JA
J Surg Res; 1992 May; 52(5):448-53. PubMed ID: 1619912
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effects of Newcastle Disease Virus in vivo: local versus systemic effects.
Schirrmacher V; Griesbach A; Ahlert T
Int J Oncol; 2001 May; 18(5):945-52. PubMed ID: 11295039
[TBL] [Abstract][Full Text] [Related]
7. Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus.
Vigil A; Park MS; Martinez O; Chua MA; Xiao S; Cros JF; Martínez-Sobrido L; Woo SL; García-Sastre A
Cancer Res; 2007 Sep; 67(17):8285-92. PubMed ID: 17804743
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the oncolytic potential of R
Sharma KK; Kalyani IH; Mohapatra J; Patel SD; Patel DR; Vihol PD; Chatterjee A; Patel DR; Vyas B
Arch Virol; 2017 Sep; 162(9):2705-2713. PubMed ID: 28578522
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid enhances killing of neuroblastoma cells by Newcastle disease virus.
Reichard KW; Lorence RM; Katubig BB; Peeples ME; Reyes HM
J Pediatr Surg; 1993 Oct; 28(10):1221-5; discussion 1225-6. PubMed ID: 8263678
[TBL] [Abstract][Full Text] [Related]
10. Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy.
Cheng X; Wang W; Xu Q; Harper J; Carroll D; Galinski MS; Suzich J; Jin H
J Virol; 2016 Jun; 90(11):5343-5352. PubMed ID: 27009956
[TBL] [Abstract][Full Text] [Related]
11. Suppression of human colon tumor growth by adenoviral vector-mediated NK4 expression in an athymic mouse model.
Jie JZ; Wang JW; Qu JG; Hung T
World J Gastroenterol; 2007 Apr; 13(13):1938-46. PubMed ID: 17461494
[TBL] [Abstract][Full Text] [Related]
12. Antitumor efficacy of viral therapy using genetically engineered Newcastle disease virus [NDV(F3aa)-GFP] for peritoneally disseminated gastric cancer.
Song KY; Wong J; Gonzalez L; Sheng G; Zamarin D; Fong Y
J Mol Med (Berl); 2010 Jun; 88(6):589-96. PubMed ID: 20393691
[TBL] [Abstract][Full Text] [Related]
13. Recombinant Newcastle disease virus as a vaccine vector for cancer therapy.
Vigil A; Martinez O; Chua MA; García-Sastre A
Mol Ther; 2008 Nov; 16(11):1883-90. PubMed ID: 18714310
[TBL] [Abstract][Full Text] [Related]
14. [Anti-tumor effect of newcastle disease virus (NDV) on human lung adenocarcinoma xenografts].
Chen Y; Xu Q; Wang L; Zhao G; Li S
Zhongguo Fei Ai Za Zhi; 2001 Feb; 4(1):29-32. PubMed ID: 21040633
[TBL] [Abstract][Full Text] [Related]
15. Construction of recombinant Newcastle disease virus Italien strain for oncolytic virotherapy of tumors.
Wei D; Sun N; Nan G; Wang Y; Liu HQ; Peeters B; Chen ZN; Bian H
Hum Gene Ther; 2012 Jul; 23(7):700-10. PubMed ID: 22372930
[TBL] [Abstract][Full Text] [Related]
16. [Antitumor research on mouse melanoma with combined application of Newcastle disease virus and its HN gene].
Mi ZQ; Jin NY; Sun YC; Li X; Lian H; Li J; Guan GF
Ai Zheng; 2004 Aug; 23(8):910-3. PubMed ID: 15301713
[TBL] [Abstract][Full Text] [Related]
17. Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells.
Jiang K; Song C; Kong L; Hu L; Lin G; Ye T; Yao G; Wang Y; Chen H; Cheng W; Barr MP; Liu Q; Zhang G; Ding C; Meng S
BMC Cancer; 2018 Jul; 18(1):746. PubMed ID: 30021550
[TBL] [Abstract][Full Text] [Related]
18. Oncolytic effect of wild-type Newcastle disease virus isolates in cancer cell lines in vitro and in vivo on xenograft model.
Yurchenko KS; Zhou P; Kovner AV; Zavjalov EL; Shestopalova LV; Shestopalov AM
PLoS One; 2018; 13(4):e0195425. PubMed ID: 29621357
[TBL] [Abstract][Full Text] [Related]
19. Analysis of three properties of Newcastle disease virus for fighting cancer: tumor-selective replication, antitumor cytotoxicity, and immunostimulation.
Fournier P; Bian H; Szeberényi J; Schirrmacher V
Methods Mol Biol; 2012; 797():177-204. PubMed ID: 21948477
[TBL] [Abstract][Full Text] [Related]
20. Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors.
Yaacov B; Eliahoo E; Lazar I; Ben-Shlomo M; Greenbaum I; Panet A; Zakay-Rones Z
Cancer Gene Ther; 2008 Dec; 15(12):795-807. PubMed ID: 18535620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
